Both in Pharmaceuticals
Sunshine Biopharma vs Ernexa Therapeutics
Over the past year SBFM returned −99.2% and ERNA returned −95.2%; their daily moves had a correlation of 0.02.
SBFM −99.2% ERNA −95.2%Growth of $1, one year, split-adjusted
| Metric | SBFM | ERNA |
|---|---|---|
| Price | $2.76 | $2.00 |
| Market cap | $2.0M | $2.3M |
| Today | −5.97% | +1.52% |
| 1 month | −79.3% | −32.4% |
| 6 months | −98.7% | −46.5% |
| Year to date | −98.9% | −93.3% |
| 1 year | −99.2% | −95.5% |
| Revenue growth (YoY) | −1.6% | — |
| Gross margin | 26.2% | — |
| Net margin | −16.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.1× | — |
| Net cash | $13.7M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 896.4% | 79.8% |
| Short % of float | 5.9% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).